What technical signals does ImmunityBio (IBRX) have?

ImmunityBio current technical signals: MA alignment (score 0.68).

Is ImmunityBio a cup-and-handle pattern?

No. ImmunityBio has no valid Cup signal right now.

What published figures are available for ImmunityBio?

Market cap: $10.14B. Trailing 12 months PER: -10.9×. Latest quarter PBR: -10.33×. Dividend yield: 0.00%.

← Signal Board

ImmunityBio stock price

이뮤니티바이오NASDAQ:IBRX · Nasdaq · Healthcare

$10.29+10.83%

2026-10-02 close

Today's signals · MA aligned

Signal details →

ImmunityBio last closed at $10.29 (+10.83%) on 2026-10-02. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is -10.9×. Its overall grade ranks 7 of 739 stocks in Healthcare.

About this company

ImmunityBio last closed at $10.29 (+10.83%) on 2026-10-02. Signals today: MA aligned. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A+ · 7/739

Valuation grade A+

Details →

Related stocks

NantKwestRelated theme
ImmunityBio와 같은 창업자·기술축(면역치료)에서 형성된 핵심 연계 기업
Bristol-Myers SquibbCompetitor
면역항암제·세포치료 영역에서 경쟁하는 대형 제약사
MerckCompetitor
종양면역치료 시장에서 경쟁하는 대표 빅파마

Details →

ETFs holding this stock

Golden Eagle Dynamic Hypergrowth ETF

Details →

About ImmunityBio

What technical signals does ImmunityBio (IBRX) have?: ImmunityBio current technical signals: MA alignment (score 0.68).
Is ImmunityBio a cup-and-handle pattern?: No. ImmunityBio has no valid Cup signal right now.
What published figures are available for ImmunityBio?: Market cap: $10.14B. Trailing 12 months PER: -10.9×. Latest quarter PBR: -10.33×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗